Evidence map›Paper›PMID 36911526›Full record

ArticleFrontiers in molecular biosciences2023

Alterations in circulating lipidomic profile in patients with type 2 diabetes with or without non-alcoholic fatty liver disease.

Assim A Alfadda, Abdulrahman M Almaghamsi, Suphia Murad Sherbeeni, Adel N Alqutub, Abdullah S Aldosary, Arthur C Isnani, Nasser Al-Daghri, Simon D Taylor-Robinson, Rukhsana Gul

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular biosciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Assim A AlfaddaObesity Research Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Abdulrahman M AlmaghamsiObesity, Endocrine, and Metabolism Center, King Fahd Medical City, Riyadh, Saudi Arabia.
Suphia Murad SherbeeniTadaw Medical Complex and Day Surgery Center, Riyadh, Saudi Arabia.
Adel N AlqutubDepartment of Gastroenterology and Hepatology, King Fahad Medical City, Riyadh, Saudi Arabia.
Abdullah S AldosaryDepartment of Medical Imaging Administration, King Fahad Medical City, Riyadh, Saudi Arabia.
Arthur C IsnaniObesity Research Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Nasser Al-DaghriChair for Biomarkers of Chronic Diseases, Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
Simon D Taylor-RobinsonDepartment of Surgery and Cancer, St. Mary's Hospital Campus, Imperial College London, London, United Kingdom.
Rukhsana GulObesity Research Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diabeteslipidomicsmetabolomicsnon-alcoholic fatty liver (NAFLD)nuclear—magnetic resonance

Identifiers

PMID36911526
PMCPMC9999296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.